Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports multiple transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, according to a Form 4 filing with the SEC.

Summary

• Mark Dmytruk, the CFO of Ginkgo Bioworks Holdings, filed a Form 4 with the SEC detailing changes in beneficial ownership.
• The transactions include the acquisition of Class A Common Stock through the vesting of Restricted Stock Units (RSUs) and the conversion of Class B Common Stock to Class A Common Stock.
• Dmytruk also disposed of Class A Common Stock to cover tax withholding obligations related to the vesting of RSUs.
• On May 1, 2024, Dmytruk acquired 65,450 shares of Class A Common Stock through RSU vesting.
• Also on May 1, 2024, Dmytruk acquired 18,125 and 22,917 shares of Class A Common Stock through RSU vesting.
• Dmytruk converted 1,635 shares of Class B Common Stock into Class A Common Stock on May 1, 2024.
• On May 2, 2024, Dmytruk sold 47,806 shares of Class A Common Stock at a price of $0.845 per share.
• Following these transactions, Dmytruk directly owns 925,400 shares of Class A Common Stock and 627,050 shares of Class B Common Stock, including shares subject to vesting conditions.
• Dmytruk also holds 646,986, 616,250 and 1,054,167 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of company leadership.
• The sale of shares to cover tax obligations is a common practice and generally doesn't have a significant impact on stakeholders.

Key Dates